Table 1.
Baseline Characteristics in the Eosinopenia and Non-Eosinopenia Group
| Variable | Eosinopenia Group (n = 4,060) | Non-Eosinopenia Group (n = 2,688) |
|---|---|---|
| Median age in years (25th-75th percentile) | 71.08 (58.2-80.0) | 69.45 (55.78-78.88) |
| Male sex, No. (%) | 2,483 (61.2) | 1,632 (60.7) |
| C-reactive protein, No. (%) | 4,021 (99.0) | 2,637 (98.1) |
| Median (mg/L), 25th-75th percentile (mg/L) | 94.09, 39.61-175.92 | 78.92, 28.12-148.79 |
| Procalcitonin, No. (%) | 1,907 (47.0) | 1,033 (38.4) |
| Median (ng/mL), 25th-75th percentile (ng/mL) | 0.49, 0.23-1.76 | 0.27, 0.12-0.65 |
| Leukocytes, No. (%) | 4,060 (100) | 2,688 (100) |
| Median (×109/L), 25th-75th percentile (×109/L) | 9.76, 6.33-14.35 | 10.19, 7.46-13.61 |
| Hemoglobin, No. (%) | 4,059 (100) | 2,688 (100) |
| Median (g/dL), 25th-75th percentile (g/dL) | 12.43, 10.73-13.94 | 12.14, 10.5-13.7 |
| Hematocrit, No. (%) | 4,059 (100) | 2,688 (100) |
| Median (%), 25th-75th percentile (%) | 36.81, 32.31-40.87 | 36.51, 31.66-40.66 |
| Creatinine, No. (%) | 4,041 (99.5) | 2,662 (99.0) |
| Median (mg/dL), 25th-75th percentile (mg/dL) | 1.04, 0.8-1.49 | 1.02, 0.77-1.52 |
| Asthma, No. (%) | 87 (2.1) | 76 (2.8) |
| COPDa, No. (%) | 577 (14.2) | 452 (16.8) |
| Congestive heart failure, No. (%) | 801 (19.7) | 503 (18.7) |
| Myocardial infarctionb, No. (%) | 66 (1.6) | 66 (2.5) |
| Peripheral vascular diseasec, No. (%) | 292 (7.2) | 242 (9.0) |
| Cerebrovascular disease, No. (%) | 242 (6.0) | 154 (5.7) |
| Dementia, No. (%) | 340 (8.4) | 190 (7.1) |
| Diabetes mellitus, No. (%) | 966 (23.8) | 634 (23.6) |
| Liver disease, No. (%) | 146 (3.6) | 95 (3.5) |
| Renal diseased, No. (%) | 880 (21.7) | 697 (25.9) |
Significant differences between eosininopenia and non-eosinopenia group:
a
P = .004;
b
P = .019;
c
P = .008;
d
P < .0001.